Answers are grounded in this paper and cite their sources.
This review highlights the emerging role of molecular genetic tumor markers in evaluating tumor stages and predicting recurrence in non-small cell lung cancer.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Tom Treasure (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: